These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22661188)

  • 1. Single bout of endurance exercise increases NNMT activity in the liver and MNA concentration in plasma; the role of IL-6.
    Chłopicki S; Kurdziel M; Sternak M; Szafarz M; Szymura-Oleksiak J; Kamiński K; Żołądź JA
    Pharmacol Rep; 2012; 64(2):369-76. PubMed ID: 22661188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse.
    Sternak M; Khomich TI; Jakubowski A; Szafarz M; Szczepański W; Białas M; Stojak M; Szymura-Oleksiak J; Chłopicki S
    Pharmacol Rep; 2010; 62(3):483-93. PubMed ID: 20631412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.
    Fedorowicz A; Mateuszuk Ł; Kopec G; Skórka T; Kutryb-Zając B; Zakrzewska A; Walczak M; Jakubowski A; Łomnicka M; Słomińska E; Chlopicki S
    Respir Res; 2016 Aug; 17(1):108. PubMed ID: 27581040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis.
    Mateuszuk Ł; Khomich TI; Słomińska E; Gajda M; Wójcik L; Łomnicka M; Gwóźdź P; Chłopicki S
    Pharmacol Rep; 2009; 61(1):76-85. PubMed ID: 19307695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential involvement of IL-6 in the early and late phase of 1-methylnicotinamide (MNA) release in Concanavalin A-induced hepatitis.
    Sternak M; Jakubowski A; Czarnowska E; Slominska EM; Smolenski RT; Szafarz M; Walczak M; Sitek B; Wojcik T; Jasztal A; Kaminski K; Chlopicki S
    Int Immunopharmacol; 2015 Sep; 28(1):105-14. PubMed ID: 25976094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance.
    Kannt A; Pfenninger A; Teichert L; Tönjes A; Dietrich A; Schön MR; Klöting N; Blüher M
    Diabetologia; 2015 Apr; 58(4):799-808. PubMed ID: 25596852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Methylnicotinamide ameliorates lipotoxicity-induced oxidative stress and cell death in kidney proximal tubular cells.
    Tanaka Y; Kume S; Araki H; Nakazawa J; Chin-Kanasaki M; Araki S; Nakagawa F; Koya D; Haneda M; Maegawa H; Uzu T
    Free Radic Biol Med; 2015 Dec; 89():831-41. PubMed ID: 26482866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of monkey and mouse nicotinamide N-methyltransferase (NNMT) bound with end product, 1-methyl nicotinamide.
    Swaminathan S; Birudukota S; Thakur MK; Parveen R; Kandan S; Juluri S; Shaik S; Anand NN; Burri RR; Kristam R; Hallur MS; Rajagopal S; Schreuder H; Langer T; Rudolph C; Ruf S; Dhakshinamoorthy S; Gosu R; Kannt A
    Biochem Biophys Res Commun; 2017 Sep; 491(2):416-422. PubMed ID: 28720493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse liver nicotinamide N-methyltransferase pharmacogenetics: biochemical properties and variation in activity among inbred strains.
    Scheller T; Orgacka H; Szumlanski CL; Weinshilboum RM
    Pharmacogenetics; 1996 Feb; 6(1):43-53. PubMed ID: 8845860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPLC-UV method for measuring nicotinamide N-methyltransferase activity in biological samples: evidence for substrate inhibition kinetics.
    Patel M; Vasaya MM; Asker D; Parsons RB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 921-922():87-95. PubMed ID: 23435346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse liver nicotinamide N-methyltransferase: cDNA cloning, expression, and nucleotide sequence polymorphisms.
    Yan L; Otterness DM; Craddock TL; Weinshilboum RM
    Biochem Pharmacol; 1997 Nov; 54(10):1139-49. PubMed ID: 9464457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma elevates nicotinamide N-methyltransferase activity and nicotinamide level in human glioma cells.
    Yamada K; Miyazaki T; Hara N; Tsuchiya M
    J Nutr Sci Vitaminol (Tokyo); 2010; 56(2):83-6. PubMed ID: 20495288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic effects of nicotinamide methylation on mouse brain striatum neuronal cells and its relation to manganese.
    Mori Y; Sugawara A; Tsuji M; Kakamu T; Tsuboi S; Kanda H; Hayakawa T; Fukushima T
    Environ Health Prev Med; 2012 Sep; 17(5):371-6. PubMed ID: 22249857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice.
    Neelakantan H; Vance V; Wetzel MD; Wang HL; McHardy SF; Finnerty CC; Hommel JD; Watowich SJ
    Biochem Pharmacol; 2018 Jan; 147():141-152. PubMed ID: 29155147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 1-Methylnicotinamide (MNA) on Exercise Capacity and Endothelial Response in Diabetic Mice.
    Przyborowski K; Wojewoda M; Sitek B; Zakrzewska A; Kij A; Wandzel K; Zoladz JA; Chlopicki S
    PLoS One; 2015; 10(6):e0130908. PubMed ID: 26115505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide N-methyltransferase enhances resistance to 5-fluorouracil in colorectal cancer cells through inhibition of the ASK1-p38 MAPK pathway.
    Xie X; Liu H; Wang Y; Zhou Y; Yu H; Li G; Ruan Z; Li F; Wang X; Zhang J
    Oncotarget; 2016 Jul; 7(29):45837-45848. PubMed ID: 27323852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose tissue as a source of nicotinamide N-methyltransferase and homocysteine.
    Riederer M; Erwa W; Zimmermann R; Frank S; Zechner R
    Atherosclerosis; 2009 Jun; 204(2):412-7. PubMed ID: 18996527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase.
    Ruf S; Hallur MS; Anchan NK; Swamy IN; Murugesan KR; Sarkar S; Narasimhulu LK; Putta VPRK; Shaik S; Chandrasekar DV; Mane VS; Kadnur SV; Suresh J; Bhamidipati RK; Singh M; Burri RR; Kristam R; Schreuder H; Czech J; Rudolph C; Marker A; Langer T; Mullangi R; Yura T; Gosu R; Kannt A; Dhakshinamoorthy S; Rajagopal S
    Bioorg Med Chem Lett; 2018 Mar; 28(5):922-925. PubMed ID: 29433927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N
    Ström K; Morales-Alamo D; Ottosson F; Edlund A; Hjort L; Jörgensen SW; Almgren P; Zhou Y; Martin-Rincon M; Ekman C; Pérez-López A; Ekström O; Perez-Suarez I; Mattiasson M; de Pablos-Velasco P; Oskolkov N; Ahlqvist E; Wierup N; Eliasson L; Vaag A; Groop L; Stenkula KG; Fernandez C; Calbet JAL; Holmberg HC; Hansson O
    Sci Rep; 2018 Feb; 8(1):3016. PubMed ID: 29445118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide N-methyltransferase in endothelium protects against oxidant stress-induced endothelial injury.
    Campagna R; Mateuszuk Ł; Wojnar-Lason K; Kaczara P; Tworzydło A; Kij A; Bujok R; Mlynarski J; Wang Y; Sartini D; Emanuelli M; Chlopicki S
    Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119082. PubMed ID: 34153425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.